Outcome of Glargine Insulin in Renal Impairment Patients With Diabetic Ketoacidosis
Status:
Recruiting
Trial end date:
2022-03-03
Target enrollment:
Participant gender:
Summary
The study aims to compare between the use of continuous low dose insulin infusion versus
co-administration of low dose continuous insulin infusion and early subcutaneous insulin
glargine in diabetic ketoacidosis patients with chronic renal impairment. aim to investigate
the effect of using the long acting insulin analogue glargine on the resolution time of
diabetic ketoacidosis in renal impairment patients who have altered insulin pharmacokinetics
and pharmacodynamics and the rate of adverse effects of this approach